TORONTO, Sept. 23 /CNW/ - Amorfix Life Sciences, a company focused on
treatments and diagnostics for brain wasting diseases, announced today it has
set up the EP-vCJD(TM) assay system in the Prion Laboratory at the British
National Institute for Biological Standards and Control (NIBSC) and has begun
to test fresh human blood samples as part of the ongoing assay validation
process announced earlier this year.
